Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (20,572,000)	$ (38,920,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	3,948,000	3,876,000
Amortization of loan costs	614,000	688,000
Amortization of right of use lease assets	84,000
Gain from sale of investment in real estate	(694,000)	(2,294,000)
Deferred management internalization consideration		31,800,000
Impairment	14,115,000	1,452,000
Income from DST	(143,000)	(170,000)
Changes in operating assets and liabilities
Due to/from related parties	(55,000)	3,000
Accounts payable	(1,786,000)	2,638,000
Lease liability	(84,000)
Loan fees	(44,000)	(275,000)
Assets held for sale		(54,000)
Security deposits
Other assets	(79,000)	(33,000)
Deferred revenue	18,000	106,000
Accounts Receivable	(603,000)	(305,000)
Prepaid expenses	(67,000)	(1,715,000)
Net cash used in operating activities	(5,348,000)	(3,203,000)
Cash flows from investing activities:
Building improvements	(921,000)	(1,324,000)
Fixed asset purchase	(78,000)
Proceeds from Investments	48,000	152,000
Proceeds from sale of investment in real estate	1,436,000	3,674,000
Payment of deposit made for purchase of investment in real estate or debt		(97,000)
Deposits applied to purchase of investment in real estate or debt		97,000
Net cash provided by investing activities	485,000	2,502,000
Cash flows from financing activities:
Proceeds from note payable	3,545,000	9,181,000
Payments on note payable	(2,544,000)	(5,666,000)
Distribution to non-controlling interest	(10,000)	(42,000)
Redeemed shares	(128,000)	(234,000)
Preferred dividends paid to stockholders	(750,000)	(2,250,000)
Net cash provided by financing activities	113,000	989,000
Net change in cash and cash equivalents and restricted cash	(4,750,000)	288,000
Cash and cash equivalents and restricted cash, beginning of period	11,644,000	9,435,000
Cash and cash equivalents and restricted cash, end of period	6,894,000	9,723,000
Reconciliation of Cash and Cash Equivalents and Restricted Cash:
Cash and cash equivalents at beginning of period	7,707,000	5,106,000
Restricted cash at beginning of period	3,937,000	4,329,000
Cash and cash equivalents and restricted cash at beginning of period	11,644,000	9,435,000
Cash and cash equivalents at end of period	3,466,000	6,358,000
Restricted cash at end of period	3,428,000	3,365,000
Cash and cash equivalents and restricted cash at end of period	6,894,000	9,723,000
Supplemental disclosures of cash flow information:
Interest Paid	6,297,000	6,477,000
Non-cash investing and financing activities:
Dividends declared not yet paid	1,751,000	250,000
Deposits applied to purchase of investment in real estate or financing		(97,000)
Deferred management internalization		24,800,000
Issuance of common stock - internalization		7,000,000
Payments on note payable through sale of investment in real estate	(2,500,000)	(2,000,000)
Recognition of use lease asset/liability	$ 1,393,000